Concepedia

Víctor Manuel Oyervides-Juárez

VM

Statistics

Publications

4

Citations

1.9K

H-Index

4

Active since

2020

Affiliations

Hospital Universitario Dr José Eleuterio Gonzalez(Current)

Dana-Farber Cancer Institute

Niigata University

Memorial Sloan Kettering Cancer Center

The University of Texas MD Anderson Cancer Center

Víctor Manuel Oyervides-Juárez is an author at Hospital Universitario Dr José Eleuterio Gonzalez specializing in oncology, cancer pharmacology, and oncology pharmacotherapy.

ORCID

Publications per year

2020–2024

4

Publications

4

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Toni K. Choueiri, Thomas Powles, Mauricio Burotto et al. · New England Journal of Medicine · 2021 · 1.7K citations · Full text

, , +9

696O_PR Nivolumab + cabozantinib vs sunitinib in first-line treatment for advanced renal cell carcinoma: First results from the randomized phase III CheckMate 9ER trial

Toni K. Choueiri, Thomas Powles, Mauricio Burotto et al. · Annals of Oncology · 2020 · 116 citations · Full text

, , +11

Avelumab + axitinib versus sunitinib as first-line treatment for patients with advanced renal cell carcinoma: final analysis of the phase III JAVELIN Renal 101 trial

Toni K. Choueiri, Konstantin Penkov, Hiroji Uemura et al. · Annals of Oncology · 2024 · 49 citations · Full text

, , +8

Protocol for Desensitization to Atezolizumab and Bevacizumab After Severe Anaphylaxis in the Treatment of Lung Adenocarcinoma

SN González-Díaz, RV Villarreal-González, CE De Lira- Quezada et al. · Journal of Investigational Allergology and Clinical Immunology · 2020 · 11 citations · Full text

, , +14

1–4 of 4